Pricing Log in Create free account

CervoMed Inc. (CRVO) vs Seres Therapeutics, Inc. (MCRB)

CervoMed Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. CervoMed Inc. and Seres Therapeutics, Inc. are of similar size ($21.9M and $20.8M). CervoMed Inc. grew revenue faster over the last twelve months: −58.9% against −98.3%. CervoMed Inc. has the higher net margin (0.00% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 15 metrics below, CervoMed Inc. leads on 12 and Seres Therapeutics, Inc. on 3.

Valuation

Metric CRVO MCRB Biotechnology median
P/E n/m n/m 10.60
P/S 3.61 9.25 9.40
P/B 0.63 0.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.62 49.24 9.02
Earnings yield (228.37%) (253.88%) (32.88%)
Free cash flow yield (196.71%) (323.94%) (23.13%)

Profitability

Metric CRVO MCRB Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (3,656.89%) 0.00%
Net margin 0.00% (2,209.55%) 0.00%
Free cash flow margin 0.00% (2,997.74%) 0.00%
Return on equity (107.62%) (144.35%) (51.96%)
Return on assets (94.73%) (44.85%) (46.06%)
Return on invested capital 0.00% (1,267.77%) 0.00%

Growth

Metric CRVO MCRB Biotechnology median
Revenue growth (TTM) (58.86%) (98.33%) 6.76%
EPS growth (last fiscal year) (47.52%) 0.00% 29.88%
Revenue growth, 5-year CAGR — (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVO MCRB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.57 1.65 4.97
Net debt to EBITDA 0.74 0.51 1.01

Dividend

Metric CRVO MCRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRVO MCRB Biotechnology median
Market cap 21.93m 20.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack